Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(11/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(11/week)
News
United States
(530/week)
Manufacturing
(352/week)
Energy
(282/week)
Technology
(363/week)
Other Manufacturing
(284/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Mucopolysaccharidosis
May 05, 2020
Jupiter Orphan Therapeutics, Inc. Strengthens its Advisory Positions
Dec 18, 2019
REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)
Dec 04, 2019
Hunter Syndrome Treatment Market Size, Share & Trend Analysis By Treatment, By Region And Segment Forecasts, 2019 - 2026
Oct 23, 2019
Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings
Jul 03, 2019
Mucopolysaccharidosis (MPS) Treatment Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
Jun 04, 2019
BioMarin Announces Approval of Vimizim® (elosulfase alfa) in China for Treatment of Morquio A Syndrome
Sep 05, 2018
Sangamo Announces 16 Week Clinical Results Including Reductions In Glycosaminoglycans In Phase 1/2 Trial Evaluating SB-913, A Zinc Finger Nuclease Genome Editing Treatment For MPS II (Hunter Syndrome)
Aug 17, 2018
2018 Mucopolysaccharidosis Disorders Drug Development Pipeline Review
Aug 10, 2018
First Patient Dosed in Phase 1/2 Study Evaluating SOBI003 for Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)
Aug 02, 2018
ArmaGen Receives U.S. Orphan Drug Designation for AGT-184
Jul 27, 2018
Sangamo To Host Educational Webcast With Hunter Syndrome (MPS II) Expert, Joseph Muenzer, M.D., Ph.D.
Jul 10, 2018
ArmaGen's AGT-181 52-Week Phase 1/2 Proof-of-Concept Study Results Published in Orphanet Journal of Rare Diseases
Jun 12, 2018
REGENXBIO Receives FDA Fast Track Designation for RGX-111 Gene Therapy for the Treatment of Mucopolysaccharidosis Type I
Jun 05, 2018
Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018: 12 Drugs Currently in Different Phases of Development
Jun 04, 2018
Sangamo Announces U.K. Authorization Of Clinical Trials Evaluating Zinc Finger Nuclease In Vivo Genome Editing Treatments SB-318 For MPS I And SB-913 For MPS II
Jun 04, 2018
Mucopolysaccharidosis I (Hurler Syndrome) Pipeline Analysis, H1 2018 with Profiles of ArmaGen, Angiochem and JCR Pharmaceuticals
May 15, 2018
REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation
May 15, 2018
Shire Recognizes MPS Awareness Day 2018 with Digital Campaign and Global Events Focused on Increasing Diseases Awareness
May 02, 2018
REGENXBIO Receives FDA Fast Track Designation for RGX-121 Gene Therapy for the Treatment of Mucopolysaccharidosis Type II
Apr 09, 2018
Perlara announces partnership with Multiple Sulfatase Deficiency Action Foundation
Page 1
››
Latest News
Apr 20, 2024
Port Houston Regular Commission Meeting
Apr 20, 2024
LS Cable & System Welcomes $99 Million Investment Tax Credit Under Section 48C of the Inflation Reduction...
Apr 20, 2024
Biloxi Marsh Lands Corporation Announces Unaudited Results for the First Quarter of 2024
Apr 20, 2024
Evergy Schedules Conference Call to Discuss 1st Quarter Results
Apr 20, 2024
Stem Announces Appointment of AI Industry Leader as New Independent Director
Apr 20, 2024
Clarification of Details Regarding Oceansix's Engagement with RB Milestone Group LLC
Apr 20, 2024
Eaton to announce first quarter 2024 earnings on April 30, 2024
Apr 20, 2024
Permianville Royalty Trust Announces Monthly Operational Update
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events